Mantra Systems at MEDICA 2024

Richard Jones
MEDICA 2024

Mantra Systems is looking forward to attending MEDICA 2024 - a prestigious international medical trade fair held in Düsseldorf, Germany.

A team from Mantra Systems will be attending this year’s trade fair on the 12th & 13th of November, so if you are attending, we would love to connect.

Our CEO Paul Hercock, Operations Director Richard Jones, Chief Medical Writer Dr. Gayle Louise Buchel, Chief Regulatory Officer Sandra Gopinath, and Senior Lead Medical Writer Simon Cumiskey will be present, ready to engage with industry leaders, share insights, and explore the latest breakthroughs in medical device technology.

For those attending MEDICA 2024, we invite you to connect with our representatives during the event. As a specialised medical device market access consultancy, we are eager to share insights, discuss regulatory challenges, and explore collaborative opportunities.

Back to top

Related articles

  1. A lab worker uses a pipette to fill samples.

    Finding My Passion at the Intersection of Science, Regulation, and Medical Devices

    Our Regulatory Project Lead, Shen, shares her journey from the lab bench at NIBSC to supporting medical device manufacturers at Mantra Systems.

    Shen May Khoo Shen May Khoo Regulatory Project Lead
  2. LinkedIn live webinar poster.

    From Idea to Approval: Get MDR Ready With Our LinkedIn Live

    An upcoming LinkedIn Live session with Dr. Zhong Wei Khor tailored specifically for healthtech founders.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  3. A view of the world from space.

    Going Global, Staying Grounded: Mantra Systems Moves to .com

    What began as a small consultancy in Sheffield has grown into a trusted partner in the medical device industry. Now we've made a change that reflects our international reach.

    Shona Richardson PhD Shona Richardson PhD Regulatory Project Lead
  4. A futuristic user interface is operated at a desk.

    An Overview of the UK’s 2024 Post-Market Surveillance Update

    What might mandatory PMS plans - which emphasise enhanced patient engagement and proactive risk management - mean for the industry?

    Ron Sangal Ron Sangal Lead Medical Writer
  5. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson PhD Shona Richardson PhD Regulatory Project Lead
  6. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  7. MEDICA 2023

    Mantra Systems at MEDICA 2023

    Mantra Systems is going to MEDICA 2023, the largest medical trade fair in the world. We hope to see you there.

    Shen May Khoo Shen May Khoo Regulatory Project Lead
  8. MDR Compliance Webinar - A masterclass on building a winning EU MDR strategy for your medical devices

    Build a winning EU MDR strategy for your medical devices

    Watch our CEO, Dr Paul Hercock, deliver a Mantra Systems webinar on MDR compliance strategy.

    Richard Jones Richard Jones Operations Director
  9. Simplifying the challenges posed by the new EU MDR

    Simplifying the challenges posed by the new EU MDR

    Our CEO Dr Paul Hercock was invited to speak on a Kaizen Life Sciences podcast about the challenges posed by the EU MDR.

    Victoria Cartwright Victoria Cartwright Relationship Manager
  10. EU flag

    A proposal to delay the EU MDR gets approved

    A vote in the European Parliament has decisively approved a delay to full implementation of the EU MDR by one year.

    Richard Jones Richard Jones Operations Director
  11. EU regulators may delay MDR enforcement

    EU regulators may delay MDR enforcement. Out of the woods?

    A delay of the MDR would be welcome news for many, but what would a delay mean in practice? To what extent can preparations for EU MDR be put on ice?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need support with your medical device approval strategy?

Contact us today